Flumazenil is a benzodiazepine antagonist.

**FDA-approved Indications**

- Treatment of Benzodiazepine overdose

-Adult, Category B, Class IIa

-Pediatric, Category C, Class IIb

- Reversal of Postoperative Sedation from Benzodiazepine Anesthetics

-Adult, Category B, Class IIa

-Pediatric, Category B, Class IIa

- Flumazenil injection is indicated for a complete or partial reversal of the sedative effects of benzodiazepines in conscious sedation and general anesthesia in the adult and pediatric populations. In addition, Flumazenil speeds the recovery from sedation following minor surgical procedures and shortened the post-operation monitoring period for minor surgery, resulting in earlier patient discharge.

- Flumazenil is also indicated for the management and treatment of benzodiazepine overdose in adults. It is useful in reversing coma due to benzodiazepine overdose. Flumazenil is more effective in reversing sedation or coma in benzodiazepine intoxication than patients with multiple drug overdoses.

**Non-FDA Approved Indications**

- Alcohol withdrawal syndrome

- Drug action reversal, baclofen

- Stupor, Idiopathic, recurring

- Toxicity of drug, Cannabis

- Hepatic encephalopathy

As Flumazenil has not received approval from the FDA, the advantages and disadvantages of using this drug in non-FDA-approved conditions are based on the patient's condition and the physician's judgment.